| 775 | 16 | 72 |
| 下载次数 | 被引频次 | 阅读次数 |
失眠病位主要在心，涉及肝、脾、肾。心神失养或实邪内扰、心神不宁皆可导致失眠。临证宜分清脏腑病位、标本虚实。肝郁血虚、心神失养者，常以柴胡加龙骨牡蛎汤或解郁合欢汤加减；痰热内盛，扰动心神者，常以半夏秫米汤或十味温胆汤加减；心脉瘀阻、心神不宁者，常以血府逐瘀汤加减。老年人作为特殊的群体，失眠病位多在心肾，常合并脾胃虚弱，可选用交泰丸或合用归脾汤加减，并强调对于原发病的治疗和药物因素。失眠患者也需适当使用安神药物。在安神药物配伍上，多基于辨证论治角度，结合现代药理研究精妙施用安神药物。
Abstract：The insomnia mainly occurs in the heart,involving the liver,spleen,and kidneys. Either malnu-trition of heart spirit,disturbance of excess evil,or disquieted heart spirit can lead to insomnia. It is advisable to distinguish disease locations in viscera,branch and root,and deficiency and excess in clinical practice. For syndrome of liver stagnation and blood deficiency,and malnutrition of heart spirit,Chaihu Jia Longgu Muli Decoction（柴胡加龙骨牡蛎汤） or Jieyu Hehuan Decoction（解郁合欢汤） should be applied with modification;for syndrome of internal exuberance of phlegm heat,and disturbance of heart spirit,Banxia Shumi Decoction（半夏秫米汤） or Shiwei Wendan Decoction（十味温胆汤） should be applied with modification;for syndrome of stasis and blockage in heart vessels,and disquieted heart spirit,Xuefu Zhuyu decoction（血府逐瘀汤） should be applied with modification. In the elderly,as a special group,insomnia is mostly located in the heart and kidneys,often accompanied by the weakness of spleen and stomach,and therefore Jiaotai Pill（交泰丸） or Guipi Decoction（归脾汤） can be applied with modification,and the treatment and medication factors for the primary disease should emphasized. In addition,patients with insomnia should be further treated with tranquilizing medicinals correspondingly. The compatibility of tranquilizing medicinals should be based on pattern differentiation and modern pharmacological research.
[1] PAUL S,VIDUSHA K,THILAGAR S,et al. Advancement in the contemporary clinical diagnosis and treatment strategies of insomnia disorder[J]. Sleep Med,2022,91:124-140.
[2]中国睡眠研究会.中国失眠症诊断和治疗指南[J].中华医学杂志，2017,97(24):1844-1856.
[3] MORIN C M,JARRIN D C,IVERS H,et al. Incidence,persistence,and remission rates of insomnia over 5 years[J]. JAMA Netw Open,2020,3(11):e2018782.
[4] MORIN C M,JARRIN D C. Epidemiology of insomnia:prevalence,course,risk factors,and public health burden[J]. Sleep Med Clin,2022,17(2):173-191.
[5] LOU B X,OKS M. Insomnia:pharmacologic treatment[J]. Clin Geriatr Med,2021,37(3):401-415.
[6]陈士铎医学全书[M].柳长华，主编.北京：中国中医药出版社，1999:782.
[7]严用和医学全书[M].王道瑞，申好真，主编.北京：中国中医药出版社，2006:50.
[8]张景岳医学全书[M].李志庸，主编.北京：中国中医药出版社，1999:1103.
[9]喻嘉言医学全书[M].陈熠，主编.北京：中国中医药出版社，1999.
[10]王清任.医林改错[M].穆俊霞，张文平，校注.北京：中国医药科技出版，2011:28.
[11] FEINSILVER S H. Normal and abnormal sleep in the elderly[J]. Clin Geriatr Med,2021,37(3):377-386.
[12] HWANG H,KIM K M,YUN C H,et al. Sleep state of the elderly population in Korea:nationwide crosssectional population-based study[J]. Front Neurol,2022,13:1095404.
[13] CARROLL J E,ROSS K M,HORVATH S,et al. Postpartum sleep loss and accelerated epigenetic aging[J].Sleep Health,2021,7(3):362-367.
[14] QIN Y,LIU R,WANG YX,et al. Self-reported sleep characteristics associated with cardiovascular disease among older adults living in rural eastern China:a populationbased study[J]. Clin Interv Aging,2022,17:811-824.
[15] CHANG Q S,LAI D P,FU Y Y. Mechanisms connecting insomnia to hopelessness among Chinese older adults:serial mediating roles of fatigue and social support[J]. Int J Geriatr Psychiatry,2022,37(6):10.1002/gps.5720.
[16] HILL ALMEIDA L M,FLICKER L,HANKEY G J,et al.Disrupted sleep and risk of depression in later life:a prospective cohort study with extended follow up and a systematic review and meta-analysis[J]. J Affect Disord,2022,309:314-323.
[17] SELLA E,MIOLA L,TOFFALINI E,et al. The relationship between sleep quality and quality of life in aging:a systematic review and meta-analysis[J]. Health Psychol Rev,2023,17(1):169-191.
[18]冯兆张.冯氏锦囊秘录[M].田思胜，校注.北京：中国中医药出版社，1996:363.
[19] WANG Y M,SONG M,WANG R,et al. Insomnia and multimorbidity in the community elderly in China[J].J Clin Sleep Med,2017,13(4):591-597.
[20] GREEN M E,BERNET V,CHEUNG J. Thyroid dysfunction and sleep disorders[J]. Front Endocrinol,2021,12:725829.
[21] DI PALO K E. Psychological disorders in heart failure[J]. Cardiol Clin,2022,40(2):269-276.
[22] POP G,FARCAS A,BUTUC?A,et al. Post-marketing surveillance of statins:a descriptive analysis of psychiatric adverse reactions in EudraVigilance[J]. Pharmaceuticals,2022,15(12):1536.
[23]谈泽烨，周桂，周昕.基于代谢组学的首乌藤导致肝损的研究[C]//中国毒理学会.中国毒理学会第十次全国毒理学大会论文集.广州：中国毒理学会，2023:193-194.
[24]陶丽宇.何首乌及首乌藤与肝损伤风险的相关性研究[D].上海：上海中医药大学，2019.
[25]薛静文，万国慧，李佳园，等.基于肠-脑轴理论探讨甘松对帕金森大鼠运动功能障碍的改善作用及机制[J].中草药，2023,54(9):2822-2831.
[26]钱薇.甘松新酮抗心律失常作用的应用基础研究[D].扬州：扬州大学，2020.
[27]熊永豪，冯波，牛源菲，等.合欢皮对小鼠焦虑行为影响及抗焦虑活性部位筛选[J].世界中医药，2018,13(4):790-793,798.
基本信息:
DOI：10.16295/j.cnki.0257-358x.2024.07.014
中图分类号:R256.23;R249
引用信息:
[1]翁家俊,环璐瑶,李的徽,等.徐凤芹从“心主神明”辨治失眠经验[J].山东中医杂志,2024,43(07):739-744.DOI:10.16295/j.cnki.0257-358x.2024.07.014.
基金信息:
国家自然科学基金项目（编号：82204923）; 中医药传承与创新“百千万”人才工程（岐黄工程）项目（编号：02045006）; 中国中医科学院科技创新工程项目（编号：CI2021A01406）; 国家中医药管理局全国名老中医药专家传承工作室建设项目、第七批全国老中医药专家学术经验继承项目（批文号：国中医药人教函[2022]75号）; 西苑医院“提升高水平中医医院临床研究和成果转化能力十点建设”资助项目（XYZX0101-45）
2024-07-05
2024-07-05